Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

    One of first grid investments under energy pillar of Egypt’s NWFE programme Financing includes European Union support Project will reduce annual carbon emissions by 22,584 tonnes of CO2 equivalent The European Bank for Reconstruction and Development (EBRD) is supporting Egypt’s transition to a green economy with a €200 million financing package for the Egyptian Electricity Transmission Company […] The post EBRD-backed grid investments pave way for greener Egypt appeared first on Web-Release.

    Omantel and Archangel Lightworks, a UK-based pioneer in optical and laser communications announced the signing of agreement to accelerate the future of satellite and optical communication services. The agreement creates a collaborative framework for the parties to introduce Archangel Lightworks’ innovative laser-optic satellite ground station communication technologies within Omantel’s network. Together, they aim to position […] The post Archangel Lightworks and Omantel establish a strategic partnership to bring laser communications to Oman appeared first on Web-Release.